0001209191-12-034518.txt : 20120619 0001209191-12-034518.hdr.sgml : 20120619 20120619162136 ACCESSION NUMBER: 0001209191-12-034518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120615 FILED AS OF DATE: 20120619 DATE AS OF CHANGE: 20120619 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 12915257 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-06-15 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2012-06-15 4 M 0 6500 16.32 A 138816 D Common Stock 2012-06-15 4 S 0 6500 56.37 D 132316 D Common Stock 4647 I 401(k) Common Stock 15920 I Common Stock held in trust. Employee Stock Option Grant (right to buy) 16.32 2012-06-15 4 M 0 6500 0.00 D 2013-07-14 Common Stock 6500 35800 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $56.37 (range $55.86 to $56.77). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Common stock held in grantor retained annuity trusts. Fully vested. David T. Howton, Attorney-In-Fact 2012-06-19